Literature DB >> 6127468

Neurotransmitters and CNS disease. Schizophrenia.

S H Snyder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6127468     DOI： 10.1016/s0140-6736(82)90167-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

Review 1.  Dopamine in psychiatry: a historical perspective.

Authors:  Paul Bernard Foley
Journal:  J Neural Transm (Vienna)       Date:  2019-02-13       Impact factor: 3.575

2.  Morphology of tyrosine hydroxylase-immunoreactive neurons in the human cerebral cortex.

Authors:  J P Hornung; I Törk; N De Tribolet
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

3.  The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.

Authors:  L Bucci
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Benzodiazepine receptors increase in post-mortem brain of chronic schizophrenics.

Authors:  Y Kiuchi; T Kobayashi; J Takeuchi; H Shimizu; H Ogata; M Toru
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1989

5.  Assessment of central dopaminergic function using plasma-free homovanillic acid after debrisoquin administration.

Authors:  M A Riddle; J F Leckman; D J Cohen; M Anderson; S I Ort; K A Caruso; B A Shaywitz
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

Review 6.  Genetic disorders presenting as "schizophrenia". Karl Bonhoeffer's early view of the psychoses in the light of medical genetics.

Authors:  P Propping
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

Review 7.  Neuroleptics and psychic indifference: a review.

Authors:  D Healy
Journal:  J R Soc Med       Date:  1989-10       Impact factor: 18.000
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.